2604.01810 On the Adverse Events of Semaglutide and Tirzepatide: A Pharmacovigilance Case Study
We investigate the adverse events (ADR) profiles of Semaglutide and Tirzepatide using multi-source pharmacovigilance data, finding robust gastrointestinal signals and detecting differences in specific AE ratios.